Results of a long-term follow-up study of fertility drugs suggest that there is no excessive risk of breast and ovarian cancer in patients who have undergone fertility treatment. The study was conducted on fertility patients at the Soroka University Hospital in Beer-Sheeba in Israel between 1960 and 1984, and the results are published in the May issue of Fertility and Sterility. Of the study group, 65 percent were exposed to fertility drugs as part of their infertility treatment. The data from this group was linked and compared to the Israel Cancer Registry to identify breast, ovary, uterine and cervix cancer cases through to the end of 1994.
Sources and References
-
Fertility drugs and the risk of breast and ovarian cancers: results of a long-term follow-up study
Leave a Reply
You must be logged in to post a comment.